CoreValve Prevails in German Patent Infringement Lawsuit with Edwards
A German Federal Court has found that CoreValve’s ReValving system (for transcatheter aortic valve replacement) does not infringe any of the claims of the Andersen […]
news2
Elliott Associates Submits $98 Million Lowball Bid for Endologix
The New York-based hedge fund, Elliott Associates, has offered to buy all of the outstanding shares of Endologix for $98 million or $2.25 per share. […]
NeoChord Receives Cash Infusion from Clarian Health Ventures
An infusion of capital will help NeoChord go the distance. Previously, the company had raised $1.76 million from angel investors in a convertible debt offering. […]
Quidel Secures $120 Million Credit Facility
In the midst of this credit crisis, having access to capital at favorable rates will make or break many of the smaller device firms we […]
Palomar vs. Candela: Laser Battle Heats Up
A Texas jury has found that Palomar’s products do not infringe on a Candela patent. Candela had accused eight Palomar handpieces of infringing on three […]
2008 European MedTech Summit
The 2008 European MedTech Summit, taking place in Switzerland on November 19-20th, will highlight 25 of the most promising European MedTech companies. The Summit provides […]
WebMD Faces New Competition from Waterfront Media, Revolution Health Merger
Waterfront Media and Revolution Health have signed a definitive merger agreement. Waterfront’s Everyday Health Network will now include RevolutionHealth.com and the Revolution Health Network. The […]
Natus Medical’s Continued Commitment to Growth: Acquires NeuroCom International
In a move that underscores the Natus Medical’s continued commitment to growth, the company has acquired privately held NeuroCom International for $18 million. NeuroCom develops […]
SyntheMed Raises $4 Million
SyntheMed closed on a $4.0 million private placement today. Investors were issued 10 million shares valued at $0.40 each plus 10 million three-year warrant entitling […]
Definiens Collaboration to Add Technological Muscle to Clarient’s Offerings in Personalized Medicine
In a move that could accelerate the growth of the Clarient’s biomarker business, the company announced Friday that, with Definiens, it will develop and commercialize […]